Provided that bryostatin gains approval, the most important thing in that 10k is regarding the agreement they have with Stanford for the bryologs IMO. The fact Wender and the founder of our company are working on the facilities and approvals this year at BryologyX is a big deal IMO. Bryostatin is the only well researched and tested PKCe activator and with supplies running out at NCI and our license agreement we'll be in the drivers seat for a long, long time. Of course our continued relationship with the group of researchers at West Va university is of massive importance as well and saves the company a lot of money on staff.
Some of the most revealing science and research into bryostatin and the new pufa analogs comes from the patents which are linked to Dr. Alkon in the ibox. One can spend hours gaining an understanding of how and why pkce activators restore and repair, in what doses, at what intervals, etc.
News 
Market Data 
Discover 
